Richard Boyd, Prof Alan Trounson and Dr Ian Nisbet
Funding

Biotech startup Cartherics doses up on $15 million raise for cancer treatment trials

- October 2, 2024 2 MIN READ

Melbourne biotech startup Cartherics has raised $15 million as it looks to begin trials of its cell therapy product for ovarian cancer. Cartherics, founded in 2015 by Alan Trounson, Bob Moses, and doctors Richard Boyd, Ian Nisbet and Peter Hudson, is developing immune cell therapies to treat cancer and other diseases. The startup previously raised $26… Read more »